Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

<h4>Background</h4>Chlamydia trachomatis is globally the predominant infectious cause of blindness and one of the most common bacterial causes of sexually transmitted infection. Infections of the conjunctiva cause the blinding disease trachoma, an immuno-pathological disease that is char...

Full description

Saved in:
Bibliographic Details
Main Authors: Chrissy H Roberts, Sandra Molina, Pateh Makalo, Hassan Joof, Emma M Harding-Esch, Sarah E Burr, David C W Mabey, Robin L Bailey, Matthew J Burton, Martin J Holland
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002744&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533119519260672
author Chrissy H Roberts
Sandra Molina
Pateh Makalo
Hassan Joof
Emma M Harding-Esch
Sarah E Burr
David C W Mabey
Robin L Bailey
Matthew J Burton
Martin J Holland
author_facet Chrissy H Roberts
Sandra Molina
Pateh Makalo
Hassan Joof
Emma M Harding-Esch
Sarah E Burr
David C W Mabey
Robin L Bailey
Matthew J Burton
Martin J Holland
author_sort Chrissy H Roberts
collection DOAJ
description <h4>Background</h4>Chlamydia trachomatis is globally the predominant infectious cause of blindness and one of the most common bacterial causes of sexually transmitted infection. Infections of the conjunctiva cause the blinding disease trachoma, an immuno-pathological disease that is characterised by chronic conjunctival inflammation and fibrosis. The polymorphic Killer-cell Immunoglobulin-like Receptors (KIR) are found on Natural Killer cells and have co-evolved with the Human Leucocyte Antigen (HLA) class I system. Certain genetic constellations of KIR and HLA class I polymorphisms are associated with a number of diseases in which modulation of the innate responses to viral and intracellular bacterial pathogens is central.<h4>Methodology</h4>A sample of 134 Gambian pedigrees selected to contain at least one individual with conjunctival scarring in the F1 generation was used. Individuals (n = 830) were genotyped for HLA class I and KIR gene families. Family Based Association Tests and Case Pseudo-control tests were used to extend tests for transmission disequilibrium to take full advantage of the family design, genetic model and phenotype.<h4>Principle findings</h4>We found that the odds of trachomatous scarring increased with the number of genome copies of HLA-C2 (C1/C2 OR = 2.29 BHP-value = 0.006; C2/C2 OR = 3.97 BHP-value = 0.0004) and further increased when both KIR2DL2 and KIR2DL3 (C2/C2 OR = 5.95 BHP-value = 0.006) were present.<h4>Conclusions</h4>To explain the observations in the context of chlamydial infection and trachoma we propose a two-stage model of response and disease that balances the cytolytic response of KIR expressing NK cells with the ability to secrete interferon gamma, a combination that may cause pathology. The data presented indicate that HLA-C genotypes are important determinants of conjunctival scarring in trachoma and that KIR2DL2/KIR2DL3 heterozygosity further increases risk of conjunctival scarring in individuals carrying HLA-C2.
format Article
id doaj-art-bfdedd2aeba04d50b03d2af3f96692fd
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2014-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-bfdedd2aeba04d50b03d2af3f96692fd2025-01-17T05:32:33ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-03-0183e274410.1371/journal.pntd.0002744Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.Chrissy H RobertsSandra MolinaPateh MakaloHassan JoofEmma M Harding-EschSarah E BurrDavid C W MabeyRobin L BaileyMatthew J BurtonMartin J Holland<h4>Background</h4>Chlamydia trachomatis is globally the predominant infectious cause of blindness and one of the most common bacterial causes of sexually transmitted infection. Infections of the conjunctiva cause the blinding disease trachoma, an immuno-pathological disease that is characterised by chronic conjunctival inflammation and fibrosis. The polymorphic Killer-cell Immunoglobulin-like Receptors (KIR) are found on Natural Killer cells and have co-evolved with the Human Leucocyte Antigen (HLA) class I system. Certain genetic constellations of KIR and HLA class I polymorphisms are associated with a number of diseases in which modulation of the innate responses to viral and intracellular bacterial pathogens is central.<h4>Methodology</h4>A sample of 134 Gambian pedigrees selected to contain at least one individual with conjunctival scarring in the F1 generation was used. Individuals (n = 830) were genotyped for HLA class I and KIR gene families. Family Based Association Tests and Case Pseudo-control tests were used to extend tests for transmission disequilibrium to take full advantage of the family design, genetic model and phenotype.<h4>Principle findings</h4>We found that the odds of trachomatous scarring increased with the number of genome copies of HLA-C2 (C1/C2 OR = 2.29 BHP-value = 0.006; C2/C2 OR = 3.97 BHP-value = 0.0004) and further increased when both KIR2DL2 and KIR2DL3 (C2/C2 OR = 5.95 BHP-value = 0.006) were present.<h4>Conclusions</h4>To explain the observations in the context of chlamydial infection and trachoma we propose a two-stage model of response and disease that balances the cytolytic response of KIR expressing NK cells with the ability to secrete interferon gamma, a combination that may cause pathology. The data presented indicate that HLA-C genotypes are important determinants of conjunctival scarring in trachoma and that KIR2DL2/KIR2DL3 heterozygosity further increases risk of conjunctival scarring in individuals carrying HLA-C2.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002744&type=printable
spellingShingle Chrissy H Roberts
Sandra Molina
Pateh Makalo
Hassan Joof
Emma M Harding-Esch
Sarah E Burr
David C W Mabey
Robin L Bailey
Matthew J Burton
Martin J Holland
Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
PLoS Neglected Tropical Diseases
title Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
title_full Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
title_fullStr Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
title_full_unstemmed Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
title_short Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
title_sort conjunctival scarring in trachoma is associated with the hla c ligand of kir and is exacerbated by heterozygosity at kir2dl2 kir2dl3
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002744&type=printable
work_keys_str_mv AT chrissyhroberts conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT sandramolina conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT patehmakalo conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT hassanjoof conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT emmamhardingesch conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT saraheburr conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT davidcwmabey conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT robinlbailey conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT matthewjburton conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3
AT martinjholland conjunctivalscarringintrachomaisassociatedwiththehlacligandofkirandisexacerbatedbyheterozygosityatkir2dl2kir2dl3